Differentiation between benign and malignant ovarian masses in the preoperative period using neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios

By  

Molecular and Clinical Oncology, Vol. 3, Iss. 2, 2015-01 ,pp. : 317-321

Science Publishers

Access to resources Recommend Favorite

Preoperative Evaluation of D-Dimer and CA 125 Levels in Differentiating Benign from Malignant Ovarian Masses

By Gadducci A.   Baicchi U.   Marrai R.   Ferdeghini M.   Bianchi R.   Facchini V.  

Gynecologic Oncology, Vol. 60, Iss. 2, 1996-02 ,pp. : 197-202

Academic Press

Access to resources Recommend Favorite

Histologic correlation with magnetic resonance imaging for benign and malignant lipomatous masses

By Rougraff Bruce T.   Durbin Mark   Lawerence Jackie   Buckwalter Kenneth  

Sarcoma, Vol. 1, Iss. 3-4, 1997-12 ,pp. : 175-179

Informa Healthcare

Access to resources Recommend Favorite

Benign pelvic masses masquerading as adnexal cancer during pregnancy on ultrasound: A retrospective study of 5 years

By        

Molecular and Clinical Oncology, Vol. 3, Iss. 6, 2015-01 ,pp. : 1395-1397

Science Publishers

Access to resources Recommend Favorite

F18-FDG-PET/CT standardised uptake value threshold in discriminating benign vs. malignant lesions. Doubts and certainties in the era of evidence-based medicine

By Bertagna Francesco   Giubbini Raffaele  

Acta Oncologica, Vol. 51, Iss. 1, 2012-01 ,pp. : 122-144

Informa Healthcare

Access to resources Recommend Favorite